linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company Background  
Aurobindo Pharma Ltd.
 
Industry : Pharmaceuticals & Drugs House : Aurobindo
BSE Code 524804
ISIN Demat INE406A01037
Book Value 369.16
NSE Code AUROPHARMA
Dividend Yield % 0.00
Market Cap 678899.02
P/E 33.60
EPS 34.79
Face Value 1  
 
Incorporation Year 26-12 1986  
Registered Office Plot No. 2,Maitrivihar ,Ameerpet, Hyderabad,
Telangana-500038 .
ISINNO INE406A01037  
Phone 040-23736370 / 23747340  
E-mail info@aurobindo.com
URL www.aurobindo.com
Industry Pharmaceuticals & Drugs  
Chairman Mangalam Ramasubramanian Kumar  
Managing Director K Nityananda Reddy  
Company Secretary B Adi Reddy  
Listing BSE,NSE  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.